SWHR, ACOG, and WFRC called for sustained funding after a new women’s health executive order.
|Articles|August 31, 2020
New practice risks post COVID-19
Author(s)Lindsey Carr, Editor
Although everyone is eager to return to normal, it is important that it is done safely.
Advertisement
Reopening decisions are happening across the country, and it is important to consider certain facets to ensure a safe opening for providers and patients.
In a recent interview with Karin Torpey Bashaw, Vice President of Patient Safety and Risk Management with The Doctors Company, Medical Economics discusses how physicians can prepare to reopen and manage risks in the new normal.
Advertisement
Related to this article
Real-world fezolinetant (Veozah) sleep data help ob-gyns counsel patients hesitant about hormone therapy, according to Marla Shapiro, CM, MDCM.
Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.
Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
In September, the FDA accepted an extended duration sNDA for the IUD with a decision expected in Q2 2027.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
ACOG issued its most comprehensive menopause guidance, grading treatments for VMS, sleep, and mood symptoms.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG guideline expands menopause VMS, sleep, and mood recommendations
2
Executive order directs NIH to create women's health division
3
Actigraphy and Objective Sleep Outcomes in Menopause VMS Treatment
4
Organon reports interim phase 3 data for MIUDELLA IUD through 6 years
5